Alembic Pharmaceuticals posted its results for the quarter ended December 2024 (Q3FY25). Its consolidated net profit tumbled ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...

Titan’s revenue from operations in Q3FY25 is estimated to grow 25% YoY, while its net profit is expected to remain flat due ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

On Saturday, after market hours, Aarti Industries posted a 63 per cent decline in its consolidated net profit of Rs 46 crore ...

Divi's Labs also said in its exchange filing that it has commenced commercial operations from a part of the Phase 1 of the ...

Booz Allen Hamilton (BAH) reported Q3 EPS of $1.55, beating estimates of $1.51. Sales of $2.92B and backlog growth of 14.8% ...